Status:

COMPLETED

Creatine Supplementation and Cognitive and Physical Tests

Lead Sponsor:

Vrije Universiteit Brussel

Conditions:

Healthy

Creatine Supplementation

Eligibility:

All Genders

18-35 years

Phase:

NA

Brief Summary

To assess whether brain creatine availability has an effect on cognition. To do so we will seek to increase brain creatine concentration via a creatine supplementation protocol.

Eligibility Criteria

Inclusion

  • Healthy (No neurological illness including cardiovascular, renal, and endocrine disorder)
  • Male/female
  • No medication / supplements
  • Non-smoker
  • Low to moderately active
  • Between 18 and 35 years old

Exclusion

  • Injuries
  • Illness
  • Use of medication
  • Use of creatine in the last 3 months
  • History of head trauma or seizure
  • Vegetarian diet \[24\]
  • Not being able to follow up the restrictions and prohibitions for the subjects (see Restrictions and prohibitions for the subjects)

Key Trial Info

Start Date :

September 10 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 28 2019

Estimated Enrollment :

14 Patients enrolled

Trial Details

Trial ID

NCT03352128

Start Date

September 10 2018

End Date

March 28 2019

Last Update

October 8 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Human Physiology and Sports Physiotherapy Research Group

Brussels, Belgium